Get the Stockscreener App
13.94
5.23%
-0.77
After Hours:
13.72
-0.22
-1.58%
Xencor Inc stock is traded at $13.94, with a volume of 1.02M.
It is down -5.23% in the last 24 hours and up +18.44% over the past month.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
See More
Previous Close:
$14.71
Open:
$14.49
24h Volume:
1.02M
Relative Volume:
0.91
Market Cap:
$994.24M
Revenue:
$133.62M
Net Income/Loss:
$-177.37M
P/E Ratio:
-4.8235
EPS:
-2.89
Net Cash Flow:
$23.50M
1W Performance:
-2.31%
1M Performance:
+18.44%
6M Performance:
+23.80%
1Y Performance:
-34.43%
1-Day Range:
$13.43
$14.76
1-Week Range:
$13.43
$15.50
52-Week Range:
$6.92
$27.24
Xencor Inc Stock (XNCR) Company Profile
Name
Xencor Inc
Sector
Industry
Phone
626-305-5900
Address
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
13.94 | 1.05B | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-25 | Upgrade | Barclays | Underweight → Overweight |
| Sep-17-25 | Resumed | Barclays | Underweight |
| Sep-03-25 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-21-25 | Initiated | William Blair | Outperform |
| Dec-12-24 | Initiated | Wells Fargo | Overweight |
| Dec-02-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-16-24 | Reiterated | BTIG Research | Buy |
| Feb-28-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-19-23 | Initiated | BofA Securities | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Oct-13-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Jan-21-22 | Initiated | SMBC Nikko | Outperform |
| Dec-15-21 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Feb-24-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-04-20 | Initiated | Barclays | Underweight |
| Feb-25-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-30-20 | Initiated | RBC Capital Mkts | Outperform |
| Nov-20-19 | Resumed | Guggenheim | Neutral |
| Aug-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-13-19 | Initiated | Mizuho | Buy |
| Apr-12-19 | Initiated | Guggenheim | Buy |
| Mar-27-19 | Initiated | Berenberg | Buy |
| Mar-15-19 | Initiated | Raymond James | Outperform |
| Sep-10-18 | Resumed | BTIG Research | Buy |
| Mar-28-18 | Resumed | Leerink Partners | Outperform |
| Mar-02-17 | Initiated | Instinet | Neutral |
| Mar-02-17 | Reiterated | Wedbush | Outperform |
| Oct-04-16 | Initiated | Piper Jaffray | Overweight |
| Dec-22-15 | Initiated | Canaccord Genuity | Buy |
| Aug-05-15 | Reiterated | MLV & Co | Buy |
| Feb-12-15 | Reiterated | Oppenheimer | Outperform |
| Jan-28-15 | Reiterated | MLV & Co | Buy |
| Jul-11-14 | Initiated | Oppenheimer | Outperform |
View All
Xencor Inc Stock (XNCR) Latest News
Can volume confirm reversal in Xencor Inc.Stock Surge & Real-Time Market Sentiment Alerts - newser.com
Is Xencor Inc. stock gaining market shareWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
Is Xencor Inc. (XE9) stock undervalued historicallyJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
What candlestick patterns are forming on Xencor Inc.Stop Loss & Capital Protection Trade Alerts - newser.com
Xencor Inc. stock trend forecastWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
Will Xencor Inc. stock split again soonWeekly Investment Report & Verified Stock Trade Ideas - newser.com
Tick level data insight on Xencor Inc. volatilityRisk Management & Reliable Entry Point Trade Alerts - newser.com
Why institutional investors increase stakes in Xencor Inc. (XE9) stockQuarterly Trade Report & Technical Entry and Exit Tips - newser.com
How Xencor Inc. stock compares to growth peersMarket Growth Report & Comprehensive Market Scan Reports - newser.com
Will Xencor Inc. (XE9) stock return to pre crash levelsJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - newser.com
Forecasting Xencor Inc. price range with options dataInsider Selling & Verified Entry Point Signals - newser.com
What MACD and RSI say about Xencor Inc.Stock Surge & AI Based Buy and Sell Signals - newser.com
Why analysts remain bullish on Xencor Inc. stock2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
Using Python tools to backtest Xencor Inc. strategiesPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
Should you hold or exit Xencor Inc. nowEarnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Tools to assess Xencor Inc.’s risk profileJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
Why Xencor Inc. stock remains on buy listsQuarterly Portfolio Summary & Community Consensus Trade Alerts - newser.com
Xencor Inc. stock chart pattern explainedGlobal Markets & Reliable Intraday Trade Plans - newser.com
Xencor, Inc. (XNCR) Stock forecasts - Yahoo! Finance UK
Xencor, Inc. (XNCR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Xencor, Inc. (XNCR) stock forecast and price target - Yahoo! Finance UK
Xencor upgraded to Overweight from Underweight at Barclays - MSN
Can Xencor Inc. stock continue upward trendQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Xencor Earns Relative Strength Rating Upgrade; Hits Key Benchmark - MSN
Why Xencor Inc. stock is favored by pension fundsJuly 2025 Update & Consistent Return Strategy Ideas - newser.com
Xencor Inc expected to post a loss of 69 cents a shareEarnings Preview - TradingView
How Xencor Inc. (XE9) stock benefits from digital adoptionJuly 2025 Volume & Verified High Yield Trade Plans - newser.com
Is Xencor Inc. (XE9) stock nearing a technical breakoutEarnings Risk Summary & Technical Buy Zone Confirmation - newser.com
Xencor Inc Stock (XNCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):